Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Genovese

Showing results (11-20 of 172) with videos related to

Pageof 18
Sort By:
Archives of Dermatology|June 20, 2007
A pilot trial of rituximab in the treatment of patients with dermatomyositisLorinda Chung, Mark C Genovese, David F Fiorentino
The Lancet. Rheumatology|January 26, 2024
Vagus nerve stimulation in rheumatoid arthritis - Authors' replyMark C Genovese, Yaakov A Levine, David Chernoff
Molecular and Cellular Biochemistry|September 7, 2011
IL-17 receptor and its functional significance in psoriatic arthritisSiba P Raychaudhuri, Smriti K Raychaudhuri, Mark C Genovese
Annals of the Rheumatic Diseases|April 17, 2016
Efficacy of VX-509 (decernotinib) in combination with a disease-modifying antirheumatic drug in patients with rheumatoid arthritis: clinical and MRI findingsMark C Genovese, Fang Yang, Mikkel Østergaard, et al.
Arthritis and Rheumatism|April 4, 2006
Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritisLarry W Moreland, Mark C Genovese, Reiko Sato, et al.
RMD Open|May 7, 2020
Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studiesMark C Genovese, Herbert Kellner, Yasumasa Arai, et al.
Arthritis Research & Therapy|February 26, 2004
A randomized, controlled trial of interferon-beta-1a (Avonex(R)) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626]Mark C Genovese, Eliza F Chakravarty, Eswar Krishnan, et al.
The Journal of Rheumatology|June 17, 2019
Methotrexate in the Treatment of Idiopathic Granulomatous MastitisAnna Postolova, Megan L Troxell, Irene L Wapnir, et al.
International Journal of Rheumatic Diseases|August 28, 2020
Immunogenicity of an adalimumab biosimilar, FKB327, and its reference product in patients with rheumatoid arthritisRieke Alten, Colin Markland, Malcolm Boyce, et al.
Arthritis Research & Therapy|April 18, 2015
Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritisMarshelle S Warren, Steven G Hughes, Walter Singleton, et al.
Pageof 18

Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
Archives of Dermatology|June 20, 2007
A pilot trial of rituximab in the treatment of patients with dermatomyositisLorinda Chung, Mark C Genovese, David F Fiorentino
The Lancet. Rheumatology|January 26, 2024
Vagus nerve stimulation in rheumatoid arthritis - Authors' replyMark C Genovese, Yaakov A Levine, David Chernoff
Molecular and Cellular Biochemistry|September 7, 2011
IL-17 receptor and its functional significance in psoriatic arthritisSiba P Raychaudhuri, Smriti K Raychaudhuri, Mark C Genovese
Annals of the Rheumatic Diseases|April 17, 2016
Efficacy of VX-509 (decernotinib) in combination with a disease-modifying antirheumatic drug in patients with rheumatoid arthritis: clinical and MRI findingsMark C Genovese, Fang Yang, Mikkel Østergaard, et al.
Arthritis and Rheumatism|April 4, 2006
Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritisLarry W Moreland, Mark C Genovese, Reiko Sato, et al.
RMD Open|May 7, 2020
Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studiesMark C Genovese, Herbert Kellner, Yasumasa Arai, et al.
Arthritis Research & Therapy|February 26, 2004
A randomized, controlled trial of interferon-beta-1a (Avonex(R)) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626]Mark C Genovese, Eliza F Chakravarty, Eswar Krishnan, et al.
The Journal of Rheumatology|June 17, 2019
Methotrexate in the Treatment of Idiopathic Granulomatous MastitisAnna Postolova, Megan L Troxell, Irene L Wapnir, et al.
International Journal of Rheumatic Diseases|August 28, 2020
Immunogenicity of an adalimumab biosimilar, FKB327, and its reference product in patients with rheumatoid arthritisRieke Alten, Colin Markland, Malcolm Boyce, et al.
Arthritis Research & Therapy|April 18, 2015
Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritisMarshelle S Warren, Steven G Hughes, Walter Singleton, et al.
Pageof 18